CytomX News

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer Landau Jeffrey B

Aug 23 06:05

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer BELVIN MARCIA

Aug 23 06:05

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer ROWLAND LLOYD A

Aug 23 06:05

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer Ogden Christopher

Aug 23 06:05

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Sean A.

Aug 23 06:00

CytomX | EFFECT: Others

Aug 20 18:04

CytomX | CORRESP: CORRESP

Aug 16 01:40

CytomX | UPLOAD: Others

Aug 16 01:40

CytomX | S-3: Registration statement for specified transactions by certain issuers

Aug 10 04:09

CytomX | 10-Q: Q2 2024 Earnings Report

Aug 9 04:50

CytomX | 8-K: CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 9 04:15

CytomX | 8-K: Current report

Jun 18 04:40

CytomX | 4: Statement of changes in beneficial ownership of securities-Officer Ogden Christopher

Jun 15 04:31

CytomX | SC 13G: Statement of acquisition of beneficial ownership by individuals-Janus Henderson Group plc(5.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.3%)

May 23 04:11

CytomX | 4: Statement of changes in beneficial ownership of securities-Director Su Zhen

May 18 05:39

CytomX | 4: Statement of changes in beneficial ownership of securities-Director Young Matthew P.

May 18 05:39

CytomX | 4: Statement of changes in beneficial ownership of securities-Director Mohindru Mani

May 18 05:38

CytomX | 4: Statement of changes in beneficial ownership of securities-Director Meyers James R

May 18 05:38

CytomX | 4: Statement of changes in beneficial ownership of securities-Director Jones Elaine V

May 18 05:38

CytomX | 4: Statement of changes in beneficial ownership of securities-Director Ashworth Alan

May 18 05:34